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The goal of the present study was to determine whether peptidylarginine deiminase PAD2 and PAD4 enzymes are present in Balb/c
mouse salivary glands and whether they are able to citrullinate Ro and La ribonucleoproteins. Salivary glands from Balb/cmice were
cultured in DMEM and supplemented with one of the following stimulants: ATP, LPS, TNF, IFNγ, or IL-6. A control group without
stimulant was also evaluated. PAD2, PAD4, citrullinated peptides, Ro60, and La were detected by immunohistochemistry and
double immunofluorescence. PAD2 and PAD4 mRNAs and protein expression were detected by qPCR and Western blot
analysis. PAD activity was assessed using an antigen capture enzyme-linked immunosorbent assay. LPS, ATP, and TNF
triggered PAD2 and PAD4 expression; in contrast, no expression was detected in the control group (p < 0 001). PAD
transcription slightly increased in response to stimulation. Additionally, PAD2/4 activity modified the arginine residues of a
reporter protein (fibrinogen) in vitro. PADs citrullinated Ro60 and La ribonucleoproteins in vivo. Molecular stimulants induced
apoptosis in ductal cells and the externalization of Ro60 and La ribonucleoproteins onto apoptotic membranes. PAD enzymes
citrullinate Ro and La ribonucleoproteins, and this experimental approach may facilitate our understanding of the role of
posttranslational modifications in the pathophysiology of Sjögren’s syndrome.
1. Introduction
In certain autoimmune diseases, components of the immune
response recognize epitopes at peptidylarginine to peptidylci-
trulline posttranslationally modified residues. This catalytic
pathway involves the activity of peptidylarginine deiminases
(PADs), which induce a hydrolytic reaction in arginine that
results in protein citrullination. This stereochemical process
modifies the physicochemical behaviour of the target protein
by increasing its antigenicity [1].
PADs are a family of calcium-dependent enzymes that
possess the following isoforms: PAD1, PAD2, PAD3, PAD4,
and PAD6, which are encoded by four different genes [2].
PADs are involved in basic processes of cell physiology such
as fertilization and embryo development; the citrullination
of histones by PAD4 antagonize the histone methylation
induced by the histone arginine methyltransferase and affect
the gene expression [3–5]. Likewise, PADs participate in the
terminal differentiation of the skin [6].
DeregulationofPADactivity is involved in thepathophys-
iology of autoimmune diseases, and protein citrullination is
considered an extraordinary mechanism for producing
autoantigens of clinical importance in rheumatoid arthritis,
optic myelitis, and other autoimmune diseases. Additionally,
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the citrullination of proteins and histones plays a role in the
pathogenesis of cancer [7].
Sjögren’s syndrome is an autoimmune disease that pri-
marily affects the salivary and lachrymal glands. Clinically,
it manifests as dryness of the eyes and mouth. The patho-
genic immune mechanisms underlying Sjögren’s syndrome
initially involve the innate immune system. Subsequently,
adaptive immune mechanisms activate B and T cells, with
the production of B cell activating factor, which is a member
of the TNF family. Together with interferon (IFNγ), B cell
activating factor contributes to cellular infiltration, which
induces the formation of lymphocytic foci in the salivary
glands the hallmark of Sjögren’s syndrome [8].
In rheumatoid arthritis (RA), citrullinated peptides trig-
ger an autoimmune reaction that results in the production
of cyclic citrullinated peptide antibodies (CCP antibodies),
which is considered to be an early specific marker of RA. In
primary Sjögren’s syndrome, 10% of patients are positive
for CCP antibodies [9]. Nevertheless, the origin and patho-
logical significance of CCP antibodies in Sjögren’s syndrome
are merely speculative. Therefore, we studied the salivary
glands of patients with Sjögren’s syndrome to identify the
catalytic machinery responsible for protein citrullination.
Our previous findings revealed the presence of PAD enzymes
and citrullinated proteins in the salivary glands of patients
with Sjögren’s syndrome [10].
Given the aforementioned results, we hypothesized that
under certain stress conditions, PAD enzymes in the salivary
glands might be activated and citrullinated Ro60 and La ribo-
nucleoproteins, which are considered to be relevant antigens
in Sjögren’s syndrome. The Ro60 protein is donut-shaped
that displays binding sites for RNA, this ribonucleoprotein
has localization in the nucleus and cytoplasm, and its func-
tion depends on where it is located. Ro60 ribonucleoprotein
is associated with one or more hYRNAs; therefore, these
small noncoding RNAs may form complexes with Ro60
and probably they have the function of cavity keeper Ro60
in preventing binding of misfolded ncRNAs [11]. La or SSB
autoantigen is a 48 kDa protein that works as a transcription
termination factor of RNA polymerase III; therefore, La
ribonucleoprotein participates in the folding and maturation
of RNA polymerase III transcripts, protecting them against
the exonuclease degradation, and this ribonucleoprotein is
critical to stabilize some nascent pre-miRNA [12]. Hence,
anti-Ro antibodies in Sjögren disease can be detected in 70–
100% of patients, while La/SSB in the 40–90%, respectively
[13]; in consequence, it is of interest to define whether PAD
enzymes could affect the expression and antigenic modifica-
tion of these ribonucleoproteins which are major targets of
the autoimmune response in Sjögren.
However, it was difficult to test our hypothesis because
the in vivo conditions required for the activation of PAD
enzymes are unknown. Furthermore, it is equally difficult to
obtain salivary glands from patients with Sjögren’s syndrome
to develop in vitro assays.
Because different molecules, such as ATP, LPS, and TNF,
can activate PAD enzymes in vitro and such molecules may
simultaneously activate the inflammasome, a pathway capa-
ble of inducing apoptosis [14–16], we designed a model of
PAD enzyme activation using the parotid glands of female
Balb/c mice and different molecules to stimulate PAD activ-
ity, this model is simple, because these animals possess big
parotid glands of easy access for surgical extraction.
The aim of the present study was to answer the follow-
ing questions: (1) Are PAD2 and PAD4 enzymes present
in mouse salivary glands? (2) Is it possible to induce PAD
activity? (3) If so, is PAD activity dependent on transcrip-
tion? (4) Are the induced PAD enzymes functional? (5) Are
the induced PADs able to citrullinate Ro and La
ribonucleoproteins?
To address these questions, the salivary glands of Balb/c
mice were cultured and stimulated with different molecules,
and PAD enzymes and citrullinated proteins were assessed.
2. Materials and Methods
2.1. Tissue Culture. The parotid glands from five female
Balb/c mice were obtained by dissection and were used
in each experimental condition. The animals were eutha-
nized, and then the parotid glands were excised under
aseptic conditions. The mass of tissue was standardized
by weight, and also after extraction, protein and mRNA
were standardized by spectrophotometry in each salivary
gland sample. All experimental procedures with animals
were performed according to the Mexican Guidelines for
the Production, Care, and Use of Laboratory Animals
(NOM-062-ZOO-1999) and the International Guide for the
Care and Use of Laboratory Animals, and experiments were
performed according to the guidelines for ethical conduct
in the care and use of animals developed by the American
Psychological Association (APA) (http://www.apa.org/
science/anguide.html). The protocol number UAZ-2013-
36474 for animal experiments was approved by the Bioethics
Committee of our Institution.
The tissues were rinsed with sterile phosphate-buffered
saline (PBS) and cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma, St. Louis, MO) for 3 hours at
37°C in a 5% CO2 atmosphere. The culture medium was
supplemented individually with the following stimulant mol-
ecules by group (n = 5): (A) 2mM ATP, (B) 2μg/mL of LPS,
(C) 200ng of TNF, (D) 250UI of IFNγ, (E) 200ng of IL-6,
and (F) in basal conditions without stimulant molecules;
aforementioned concentrations of the stimulant molecules
were defined in basis of previous reports by other investiga-
tors (14–16). After the incubation, the tissues were processed
as follows: one parotid gland was immersed in Tissue-Tek®,
frozen at −20°C, and the cryosections were used for direct
immunofluorescence. Another parotid gland was fixed in
10% formalin and processed for H&E staining and immuno-
histochemistry. Another set of parotid glands was used for
protein and RNA extraction, as well as for PAD isolation
for functional enzymatic assays.
2.2. CCP Antibodies. ELISA assays were used to detect anti-
bodies against citrullinated synthetic proteins. Serum from
a patient with rheumatoid arthritis was used as a positive
control, and sera from various patients with primary Sjög-
ren’s syndrome were also tested. The assays were performed
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according to the manufacturer’s instructions (Euroimmun
AG, Luebeck Germany). Serum samples diluted 1 : 100 were
incubated for 60 minutes at room temperature in wells of
polystyrene plates coated with synthetic cyclic citrullinated
peptides (CCPs) [17]. Next, the plates were washed with
washing buffer, and the bound antibodies were incubated
with conjugated HRP-rabbit polyclonal anti-human IgG
(horseradish peroxidase) for 30 minutes. Finally, the colour
reaction was developed by incubating the sample for 30
minutes with the developer pNPP (p-nitro phenyl phosphate,
disodium salt). The reaction was stopped, and the plates were
assessed using an ELISA reader at 450nm. In all experiments,
five calibrators of the kit were used to construct the standard
curve, and the results were expressed in densitometric units.
All assays were performed in triplicate.
2.3. Purification of High-Affinity CCP Antibodies and
Peroxidase Labelling. Serum from a patient with primary
Sjögren’s syndrome who was positive for CCP antibodies
was subjected to ELISA as described previously [18] with
the following modifications: after incubation, specific
CCP-bound antibodies were eluted from the CCP-coated
polystyrene plates with 0.2M glycine-HCl at a pH of 2.8.
The pH was neutralized with 1M Tris, pH9.5. This solu-
tion of purified high-affinity CCP antibodies was concen-
trated in an EMD Centriplus centrifugal concentrator
with a 30 kDa molecular weight cut-off (Fisher Scientific,
USA). The protein concentration was measured using the
Bradford method [19].
The purified high-affinity CCP antibodies were labelled
with horseradish peroxidase (HRP) (Sigma, St. Louis, MO)
using the glutaraldehyde method [20]. The molar ratio of
peroxidase to antibodies was 1 : 10. Briefly, one milligram of
the enzyme was dissolved in 0.3M sodium bicarbonate
pH8.1 and was preactivated with 500μL of 1% glutaralde-
hyde and incubated with the sample at 37°C for 30 minutes.
Excess of glutaraldehyde was quenched with 100μL 1-
fluoro-2,4-dinitrobenzene (Sigma, St. Louis, MO) dissolved
in absolute ethanol, and then the mixture was oxidized with
0.08M sodium periodate to induce the aldehyde groups, such
reaction was stopped by the addition of 0.16M ethylene
glycol (Sigma, St. Louis, MO) in distilled water; the mixture
was dialyzed in against 0.01M sodium carbonate buffer.
Additionally, protein concentration of CCP antibodies was
determined at 280nm; then, 10mg of antibodies was coupled
to peroxidase aldehyde. The coupling reaction was induced
over an 18-hour incubation at room temperature in sodium
carbonate buffer pH9.5, and this reaction was stabilized with
1mg of sodium borohydride (Sigma, St. Louis, MO). The
CCP antibody/HRP conjugate was dialysed extensively
against distilled H2O using a membrane with a pore size of
40 kDa. The CCP antibody/HRP label was then fractionated
in a Sephadex G-200 (Sigma-Aldrich, St. Louis, MO) mini-
column equilibrated with PBS. Fractions of 100μL were
collected, and the protein concentration in each fraction
was determined at 280nm. ELISA was performed to evaluate
CCP antibody activity. The affinity-purified HRP-labelled
CCP antibodies were concentrated using a Centriplus con-
centrator and used for immunohistochemistry; the final yield
conjugated antibody concentration was of 6mg. Another
fraction of affinity-purified unlabelled CCP antibodies was
used for the double immunofluorescence assays.
2.4. Immunohistochemistry. PAD2 and PAD4 enzymes, as
well as Ro60 and La ribonucleoproteins, were detected in
4μm thick sections of parotid salivary glands. The tissue
specimens were deparaffinized, permeabilized with 0.01%
Triton X-100/phosphate-buffered saline, and washed three
times with PBS. Endogenous peroxidase was quenched for
10 minutes with 3% H2O2 in methanol, followed by a block-
ing step with 3% foetal calf serum (Gibco, Thermo Fisher
Scientific). The tissues were washed and incubated for 12
hours with the appropriate dilution of specific anti-PAD2,
anti-PAD4, anti-Ro60, and anti-La antibodies. The slides
with the tissues were washed extensively with PBS and then
incubated for 2 hours with the secondary antibody. The
HRP-labelled antibodies were detected by development with
3,3-diaminobenzidine 0.06% H2O2 (Sigma, St. Louis, MO),
and the reaction was stopped with 0.5M sulfuric acid. The
slides were examined by light microscopy. All assays were
performed in triplicate and evaluated in a blinded manner.
Additionally, citrullinated proteins were detected by incuba-
tion for 12 hours with affinity-purified HRP-labelled CCP
antibodies diluted 1 : 50. After extensive washing with PBS,
the colour reaction was developed as previously described
and evaluated by light microscopy in a blinded manner [21].
2.5. Antibodies. The following antibodies were used: anti-
PAD2 antibody (PA5-19474, Thermo Scientific; diluted
1 : 100) and anti-PAD4 (PA5-2217, Thermo Scientific; diluted
1 : 100), anti-Ro60 (H-300 Sc-20961) or anti-La (sc-166274,
Santa Cruz Biotechnology; diluted 1 : 100), and anti-β-actin
(ab2072 Abcam). Peroxidase-conjugated goat anti-mouse
IgG (Sigma, St. Louis, MO) or goat anti-rabbit IgG (Abcam
ab759) was used as secondary antibody. Additionally, an
anti-citrulline antibody (231246, Calbiochem, Darmstadt,
Germany; 1 : 100 dilution in 10% foetal bovine serum (FBS)
PBS) was used for immunohistochemistry.
2.6. Primer Design. PAD2, PAD4, Ro60, and La gene expres-
sion was detected by qPCR amplification from genomic RNA
obtained from Balb/c salivary glands with the following
primers: PAD2 forward 5′-GCC TCG ACT CCT TCG
GGA-3′ and reverse 5′-ACG GGG TAC TCC TTG CCA T-
3′, PAD4 forward 5′-TGG AAG GTC TTG CTT TCC CA-3′
and reverse 5′-TCC AGC AGG GAG ATG GTG A-3′ [22],
Ro60 forward 5′-TCA CAT CTT AAA CCT TCC AGT
GA-3′ and reverse 5′-ACTT AAC ATA TTT CTT TTT
GTG AGA G-3′, La forward 5′-GAT GAA AAT GGT GCA
ACT GG-3′ and reverse 5′-CTG TTT TCT GTT GTT TGG
GAT GC-3′ [23], β-actin forward 5′TGG AAG GTC TTG
CTT TCC CA-3′ and reverse 5′-TCC AGC AGG GAG ATG
GTG A-3′ [24], and 18SrRNA forward 5′-CTA CGT CCC
TGC CCT TTG TAC A-3′ and reverse 5′-ACA CTT CAC
CGG ACC ATT CAA-3′ [25], which was used as a house-
keeping gene for qPCR analysis.
2.7. Generating cDNA by RT-PCR. Total RNA (250μg) was
isolated with TRIzol® Plus RNA purification (cat. 12183-
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555, Ambion™ by Life technologies) and standardized by UV
spectrophotometry at 260 nm; RNA was mixed with 200μM
dNTP, 0.7μM of the reverse primer, and 5U/20μl of
rTth/DNA polymerase (SuperScript™ IV reverse transcrip-
tase, Invitrogen, Thermo Fisher Scientific) and incubated at
70°C for 10 minutes. Amplification of the PAD2, PAD4,
Ro60, La, β-actin, and 18SrRNA cDNA was conducted by
PCR with 0.15mM of the forward primer consisting of
35 cycles of 94°C for 15 sec, 60°C for 30 sec, and 72°C for
1 minute. The PCR products were electrophoresed in a
2.7% agarose gel containing 0.5μg/ml ethidium bromide,
and the gels were analysed using a Molecular Imager Chemi-
Doc™XRS (Bio-Rad).
2.8. Quantitative Real-Time PCR (qPCR). qPCR was done by
incubation of 20 ng of cDNA (standardized by spectropho-
tometry at 260nm) with 10μl of Fast SYBR® Green Master
(Thermo Fisher Scientific) mix adjusting the final volume
to 20μl with H2O; mixture reaction was loaded by triplicate
in a 48 wells micro plate (Mini Plate Spinner, MPS 100, Lab
Net), and after 30 sec centrifugation, the reaction was done
in a Pixo Helixis system (Illumina San Diego, CA, USA)
consisting in an initial PCR activation of 20 sec at 95°C,
followed by 35 cycles of denaturation 3 sec at 95°C, annealing
30 sec at 60°C and extension 30 sec at 60°C except for Ro60
and La which was at 52°C. Relative quantification was
done by the comparative method (ΔCt). The expression
level of each gene was normalized using 18S gen as invari-
ant endogenous control.
2.9. Activation of PAD2 and PAD4 Proteins in Salivary
Glands. The expression of PAD2 and PAD4 proteins was
assessed in salivary gland extracts treated with ATP, LPS,
TNF, IL6, or IFNγ. Briefly, after culturing, the tissues were
washed with sterile cold PBS, pH7.2. The tissues were
disrupted by sonication in 200μl of lysis buffer (1% Triton
X-100, 140mM NaCl, 1mM EDTA, 10mM Tris-HCI,
pH7.6, and 1mM PMSF). The extracts were then centrifuged
at 14,000 rpm for 10 minutes at 4°C, and the supernatants
containing soluble fractions of salivary glands were saved
and used to detect PADs by ELISA, in functional assays,
and by Western blot analysis.
2.10. SDS-PAGE and Western Blot Analysis. After protein
quantification by spectrophotometer by the Bradford
method at 595nm and by UV coefficient extinction at
280nm, cell extracts were separated in 10% SDS-PAGE gels.
In each experimental condition, tissue extracts were stan-
dardized to load 10μL of a 2mg/mL final concentration of
protein per well [26], after electrophoresis proteins were
transferred onto nitrocellulose membranes (Hybond-C,
Amersham, UK), and then nonspecific binding of the anti-
bodies was blocked with 5% nonfat dry milk dissolved in
PBS [27]. Immunoreactive bands were identified by applying
the appropriate dilution of primary antibodies of specific
anti-PAD2 or PAD4 and anti-Ro60 (H-300 Sc-20961) or
anti-La (sc-166274, Santa Cruz Biotechnology) in 2% nonfat
dry milk, 0.3% Tween® 20, PBS, and membranes with
primary antibodies that were incubated and rocked gently
overnight at 6°C. Peroxidase-conjugated goat IgG or anti-
mouse IgG (Sigma, St. Louis, MO) served as the secondary
antibody. After a 1-hour incubation, immunoreactive bands
were detected using chemiluminescence (ECL, RPN2106;
Amersham). Moreover, citrullinated proteins were detected
using an anti-citrulline antibody (231246, Calbiochem,
Darmstadt, Germany; 1 : 100 dilution in 10% foetal bovine
serum (FBS) PBS). Chemiluminescent Western blot detec-
tion was used according to the manufacturer recommen-
dations (Immun-Star Western C chemiluminescence kit,
Bio-Rad, catalogue 170-5070), the protein band densities
were determined in a Molecular Imager ChemiDoc XRS
(Bio-Rad), and normalized values were calculated using
as control protein β-actin dividing all normalizing control
with each protein of interest.
2.11. Immunoprecipitation Assay. Immunoprecipitation
assay was done using an anti-citrulline antibody adsorbed
by Sepharose 4B-SPA (Sigma, St. Louis, MO, USA)-yielded
immunoprecipitates containing diverse citrullinated proteins
that were electrophoresed, blotted, and tagged with anti-
Ro60 or anti-La; positive Ro60 or La bands were marked with
a pencil, and then membranes were stripped and reprobed
using a Restore™ Western blot stripping buffer (Thermo
Fisher Scientific, c. 2109), after washing with Tris-buffered
saline with 0.05% Tween 20. The complete removal of pri-
mary antibody was demonstrated by lack of chemilumines-
cent signal in the imager; membranes were blocked with 3%
nonfat milk and reprobed with commercial anti-citrulline
antibodies, and the possible positive signal at the marked
level was recorded.
2.12. Antigen Capture Enzyme-Linked Immunosorbent Assay
(ACELIA). Total citrullination activity was detected in cell
extracts by ELISA, coating 96 polystyrene microtiter plates
(BD Falcon, Bedford, MA) with 100ng of soluble protein of
tissue extracts/well in a volume of 100μL PBS; active sites
were neutralized for 2 hours with 3% BSA, and then citrulli-
nation was detected by an anti-citrulline HRP-labelled
antibody at 480nm.
The ACELIA was performed to detect enzymatic activity
as previously reported with some modifications [28]. Micro-
titer 96 polystyrene plates (BD Falcon, Bedford, MA) were
coated with anti-PAD2 or PAD4 antibodies at a concentra-
tion of 100ng/well in PBS in a volume of 100μL. Antibodies
were incubated overnight at room temperature, and exposed
active sites were neutralized for 2 hours with 3% BSA. The
wells were washed with PBS and further incubated for 1 hour
at room temperature with 100μL of the salivary gland extract
supernatant containing the PAD enzymes. After incubation,
the wells were rinsed repeatedly with washing buffer, and
the PAD activity of the captured enzymes was assessed using
fibrinogen as a reporter protein. For this assay, 100 ng of
fibrinogen (F3879 Sigma, St. Louis, MO) was dissolved in
PBS and incubated for 1 hour at 37°C with immunoadsor-
bent PAD2 and PAD4 enzymes. After incubation, the
supernatant from each well was collected, fixed to the wells
of new microplates, and incubated overnight at room tem-
perature. The active sites were then blocked with 3% BSA.
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After washing with PBS, the presence of citrullinated fibrino-
gen was assessed by ELISA using an anti-citrulline HRP-
labelled antibody.
2.13. Apoptotic Features. Apoptosis was defined based on two
criteria: the classic TUNEL and Annexin assays.
2.13.1. TUNEL. This assay was performed according to the
manufacturer’s instructions (11684795910, Roche Molecular
Biochemicals, Penzberg, Germany). Nuclear stripping of the
salivary gland biopsies was performed by immersing the
slides for five minutes in 10mM Tris-HCl, pH8.0, followed
by 15 minutes in 20μg/mL proteinase K dissolved in
10mM Tris-HCl. The biopsies were then washed with PBS.
The DNA fragments were elongated by incubation for 60
minutes at 37°C with 50μL of the reaction mixture (DDW,
10x TdT buffer [30mM Tris base, 140mM sodium cacody-
late, pH7.2, 1mM cobalt chloride, and 1mM DTT], 10% of
the final volume), fluorescein-11-dUTP (0.5mg dissolved in
1mL of 10mM Tris-HCl, pH7.0), and TdT enzyme (0.3
enzyme units/μL). The reaction was terminated with stop
solution (300mM NaCl, 30mM sodium citrate, pH8.0),
and the slides were examined by fluorescence microscopy.
2.13.2. Annexin Assay. Apoptotic membranes were stained
green with FITC Annexin V (BD Pharmingen). This ratio-
nale for this assay is based on the loss of cell membrane
asymmetry during the early phases of apoptosis. Annexin V
is a calcium-dependent phospholipid-binding protein that
binds with high affinity to phosphatidylserine. The tissues
were rinsed once with a binding buffer, incubated for 15
minutes with 10μg of FITC-labelled recombinant Annexin,
and washed with PBS.
2.14. Detection of Ro60 and La Ribonucleoproteins on
Apoptotic Membranes Using the Double Fluorescence Assay.
Ro and La antigens on apoptotic membranes were detected
using double fluorescence assays. Briefly, the Ro60 and La
ribonucleoproteins were tagged in red via a 120-minute incu-
bation with an anti-Ro60 or anti-La antibody. The samples
were then incubated for 120 minutes with goat anti-mouse
IgG Texas red-labelled antibody (sc-2781, Santa Cruz Bio-
technology). After washing with PBS, the apoptotic
membranes were stained green with FITC Annexin V (BD
Pharmingen, USA) as previously described. Finally, the slides
were counterstained with DAPI, mounted, and evaluated
under a fluorescence microscope using the appropriate
filters. Additionally, double fluorescence assays for Ro and
La proteins (stained in red) were performed using the tissues
that had been processed for TUNEL (apoptotic cell were
stained green). In addition, double fluorescence assays were
performed to assess the colocalization of Ro or La ribonu-
cleoproteins (stained in green) with citrullinated proteins
(stained in red); degree of colocalization areas was analysed
by linear regression testing.
2.15. Statistical Analysis. The data were processed using the
following parametric statistics ANOVA F-test and t-test,
and also linear regression assays were carried with Prism
software (GraphPad software). p < 0 05 was considered
statistically significant.
3. Results
3.1. Salivary Gland Cultures. Excised parotid glands were
cultured for 3 hours with excellent viability; however, after
stimulation with different molecules, the rate of apoptosis
increased from 7% to 22%, in contrast to the controls cul-
tured without additional stimulants with a negligible rate of
apoptosis. Remarkably, in response to ATP stimulation, the
chromatin adopted a rim-like distribution around the
circumference of some nuclei (Figure 1).
3.2. PAD2 and PAD4 Proteins Are Induced by Molecular
Stimuli. Under basal conditions, control tissues without any
treatment were negative for PAD. However, following stimu-
lation, PAD2 and PAD4 were expressed to a great extent
along acini and ductal cells, and both enzymes were
expressed similarly in response to different stimuli, excluding
LPS and ATP, which induced discrete PAD expression. Nev-
ertheless, a significant difference was detected between con-
trols and stimulated salivary glands (p < 0 001; Figure 2).
3.3. Relative PAD2, PAD4, Ro60, and La Gene Expression.
Considering that PAD2 and PAD4 were induced and that
they appear to accumulate in response to stimulation, we
wondered whether the stimulus was capable of enhancing
the transcriptional rates of PADs. We decided to analyze
the quantitative gene expression using qPCR, and 18sRNA
was selected for validation of genes data. In addition of
PAD2 and PAD4 genes, Ro60 and La ribonucleoprotein
genes were included in this experiment. As expected, PAD2
showed up of twofold increases in response to all stimulants,
while PAD4 augmented significantly with ATP, TNF, and
IFNγ (p < 0 0001). On the other hand, Ro60 expressed
threefolds in response to LPS, whereas La ribonucleoprotein
amplified under LPS and TNF stimulation (p < 0 0001;
Figure 3).
3.4. Induction of PAD2 and PAD4 Proteins. To evaluate the
expression of PADs in each experimental condition, the pro-
tein level of samples was adjusted before loading the electro-
phoresis gels; thus, the amount of protein was similar for
both controls and problems, and then theWestern blot bands
were analyzed and their values are expressed in pixels—these
values were normalized by subtracting the β-actin values. As
expected, the presence of PAD2 and PAD4 in basal condi-
tions was discrete; however, PAD expression was increased
by the effect of certain stressors, for example, PAD2 was
increased by TNF stimulation and PAD4 under the effect of
ATP, LPS, and TNF (Figure 4).
Regarding the discrepant finding of greater expression
of messengers comparing with its cognate protein does
not mean that under certain experimental condition, the
mRNA level must necessarily predict its protein level: this
discrepancy can be explained by mRNA decay and/or
protein degradation.
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3.5. PAD Activity. We found that citrullinated proteins were
widely distributed along the acini and that the ductal epithe-
lium was accessible (Figure 2). Possible PAD activity was
explored using two assays: first, using immunohistochemis-
try, we detected citrullinated proteins at the glandular level
in vivo using a specific CCP affinity-purified antibody by a
direct ELISA that showed a significant citrullination process
in tissue extracts stimulated with TNF (p < 0 0001;
Figure 5(a)). Second, the assessment of the functionality of
PAD enzymes in vitro with ACELIA revealed significant
citrullination of the reporter protein fibrinogen in response
to ATP and TNF for PAD2 and ATP, LPS, and TNF for
PAD2 and PAD4 (p < 0 0001). In contrast, spontaneous
citrullination in the absence of a stimulus was negligible
(Figures 5(b) and 5(c)).
3.6. Induction of Ro60 and La Ribonucleoproteins by
Molecular Stimulators. To address whether Ro60 and
La ribonucleoproteins were induced in vitro, different assays
were conducted, and the following main results were
obtained. First, Ro60 and La were induced slightly in salivary
glands in response to molecular stimuli such as ATP and
LPS, as demonstrated by immunofluorescence (Figure 6).
Second, the transcriptional rate of both ribonucleopro-
teins was apparently induced by molecular stimulants, as
seen in Figure 3 by qPCR assay; such increase was true
in Ro60 induced by LPS stimuli and La mRNA under
LPS and TNF stimulation (p < 0 0001; Figure 4). Ro60
and La ribonucleoproteins are widely distributed in all tis-
sues because both are essential for cellular function; how-
ever, we must remember that its relative cellular content
is small (Figure 7), and if their values are normalized
using β-actin, in which its cellular content is superior to
those of Ro and La, the graphs in consequence will appear
as negative values; however, if the nonnormalized values of
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Figure 1: Molecular stimulants induce changes in salivary glands. (a) Morphology of H&E-stained salivary glands from Balb/c mice.
(b) TUNEL assay (lower panel) showing apoptotic changes in green or yellow in response to different triggers. Nonapoptotic cells were
counterstained red with propidium iodide. (c) The graph shows the percentage of apoptotic cells (p value calculated by ANOVA).
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Figure 3: Differential gene expression of PAD2, PAD4, Ro60, and La induced by molecular stimulants ATP, LPS, TNF, IL-6, and IFNγ by
quantitative PCR (qPCR). Graphs show the validation done by the comparative method (ΔCt). The expression level of each gene was
normalized using 18S gen as invariant endogenous control. Asterisk on the top of the bars means that induced gene expression was










ATP LPS TNF IL-6 IFN훾
Figure 2: PAD induction by stimulants. PAD2 detection by immunohistochemistry (brown stain). The expression of the enzyme is induced
by the stimuli with different molecular triggers.
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basal condition, some molecular stressors such as ATP
and LPS may increase their expression as depicted in the
Western blots of Figure 7(b).
Another important issue was to demonstrate that Ro and
La ribonucleoproteins were citrullinated, and present results
demonstrated citrullinated proteins eluted from the immu-
noadsorbent of Sepharose-4B coupled to anti-citrulline anti-
bodies; therefore, the complex of citrullinated proteins was in
the range of 60–48 kDa, and this means that PAD enzymes
drive a wide citrullination process including other than
Ro60 and La, also probably the albumin can be citrullinated,
which is a frequent contaminant of cell extracts and is within
the range of molecular weight. However, despite these con-
siderations, our results are specific because after a stringent
stripping washings, the positive membranes were marked
and reprobed with an anti-Ro or anti-La antibody and this
produced a unique and specific band corresponding Ro60
or La (48 kDa); we must mention that some blots of Ro60
showed an additional band below to 60 kDa level, specially
those cell extracts from cultures stimulated with ATP or





Control ATP LPS TNF IL-6 IFN훾 Control ATP LPS TNF IL-6 IFN훾
Control ATP LPS TNF IL-6 IFN훾
(c)
Figure 4: Different molecular triggers induce PAD enzyme expression, as assessed byWestern blot analysis. (a) PAD2 enzyme and (b) PAD4
enzyme graphs showing relatively lower levels of PAD2 and PAD4 enzymes induced by molecular triggers. Graphs were normalized by
β-actin housekeeping protein. (c) Western blot of PAD2, PAD4, and β-actin.
(a) (b) (c)
Figure 5: PAD activity. (a) In vivo PAD activity measured based on the citrullination of proteins in cell extracts using a direct ELISA
assay with tissue extracts fixed onto polystyrene plates and measuring CCP/HRP antibody, this assay shows a significant increase by TNF
(p < 0 0001). In vitro PAD2 activity under basal conditions in response to stimulation with different molecular stimulants; PADs were
captured using anti-PAD2 or anti-PAD4 enzymes, then citrullination was detected using an exogenous reporter protein (fibrinogen)
and measured with an anti-citrulline-HRP antibody by ACELIA and difference between stimulants and controls (b, c). (b) Significant
differences of in vitro citrullination PAD2 dependent by the effect of all stimulants except IFNγ (p < 0 0001); similar results were
obtained by PAD4, and bars marked with an asterisk compare control with a specific molecular stimulant by Student t-test (c).
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Figure 6: Double fluorescence assays showing colocalization. Graphs show the fluorescent expression of Ro60 and La ribonucleoproteins in
response to different molecular triggers. A representative double fluorescence assay of Ro and La (green) colocalization with citrullinated
proteins (red). Nuclei are counterstained with DAPI (blue). The green and red fluorescence was analyzed in specific areas of colocation
indicated by arrows and magnified in boxes, and the colocalization was analyzed by a regression analysis, which resulted with r2 of 0.674
for Ro60 meanwile 0.295 for La ribonucleoprotein. The asterisk on the top bars means significant differences from control (p < 0 0001,
Student t-test).
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We further tested the specificity of our findings perform-
ing an additional immunoprecipitation with Sepharose 4B
linked to anti-Ro60 (data not included); then, the immuno-
precipitated proteins were probed with an anti-citrulline
antibody producing a citrullinated protein at the level of
60 kDa, and this confirmed the first immunoprecipitation
assay depicted in Figure 7. In the case of La ribonucleopro-
tein, we did not obtain the expected results; a possible
explanation of the negative results could be due to a lower
citrullination rate of La ribonucleoprotein.
Molecular studies demonstrated that Ro60 and La are
present in salivary glands under basal conditions, and their
relative gene expression by qPCR amplified Ro60 and La
mRNAs under certain stimulants such as LPS and TNF; nev-
ertheless, the relative protein content do not increase after
stimulation, and Ro60 and La mRNA level did not predict
its correspondent protein level.
3.7. Ro60 and La Citrullinated Ribonucleoproteins Expressed
on Apoptotic Membranes. To address whether molecular
stimulants induced citrullination of Ro60 and La, different
assays were carried out: first, the effect of PAD activity on
Ro60 and La ribonucleoproteins was suggested in the double
fluorescent assays, which revealed a high degree of colocali-
zation between the native and citrullinated proteins
(r = 0.674), this suggests a broad citrullination process
(Figure 6). Second, by immunoprecipitation assay, using an
anti-citrulline antibody adsorbed by Sepharose 4B-SPA dem-
onstrated the presence of Ro60 and La ribonucleoproteins;
therefore, citrullinated Ro6o ribonucleoprotein was detected
even in control extracts (Figure 7(c)). The aforementioned
suggests that citrullination of Ro60 ribonucleoprotein occurs
in vivo at low rate even in control tissues; however, such pro-
cess is induced under ATP or IFNγ stimulation, thus the




Figure 7: Expression and citrullination of Ro60 and La ribonucleoproteins under stimulation, by Western blot analysis. (a) Graphs show net
intensity normalized for the corresponding Ro60, and La bands show a moderate increase of Ro60 induced by ATP (p < 0 0001 by t-test). La
ribonucleoprotein also shows discrete changes regarding its own control without stimulants. (b)Western blots of Ro60, La ribonucleoproteins,
and β-actin (control protein). (c) Superior panel shows immunoprecipitation assays of citrullinated proteins blotted and probed with anti-Ro
or anti-citrulline. Positive bands at 60 kDa (left) and 48 kDa (right) were marked, and membranes were then stripped and reprobed with an
anti-Ro60 (left inferior panel) and anti-La (right inferior panel). It is evident that Ro60 had a wide citrullination process specially by ATP and
IFNγ stimulation. Immunoprecipitates of La ribonucleoprotein display faint citrullination signal under ATP stimulation.
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absence of cellular stressors suggest that this process could
occur under physiological condition and we do not know
its meaning. Nevertheless, this mechanism may be relevant
in autoimmunity only if the rate of citrullination is high as
consequence of cell stress that together with an appropriate
class II molecule to handle the Ro60 as autoantigen could
result in an autoreactive response.
In contrast to La ribonucleoprotein that was immuno-
precipitated in cell extracts stimulated with IFN, the citrul-
lination tag was irrelevant and it was faintly recognized by
anti-citrulline antibodies in cell extracts stimulated by
ATP, suggesting variability in the citrullination of both
ribonucleoproteins.
Third, to demonstrate whether Ro60 and La ribonucleo-
proteins were expressed on the apoptotic membranes of
acini and ductal cells, a double fluorescence with TUNEL
or Annexin was made (principal results of this assay in
Figures 8 and 9).
4. Discussion
The present investigation was performed to construct an
experimental model to induce the expression of PAD2
and PAD4 enzymes in salivary glands using different trig-
gers. Additionally, the ability of the driven PAD enzymes
to induce the posttranslational modification of Ro60 and
La ribonucleoproteins was assessed. The main findings sug-
gest that PAD activity may be induced in salivary glands in
tissue culture by different triggers and that the induced
PAD enzymes are capable of stereochemically modifying
the arginine residues of Ro60 and La ribonucleoproteins.
Thus, these citrullinated Ro and La ribonucleoproteins may
function as autoantigens.
Peptidylarginine deiminase belongs to a family of
enzymes that convert the arginine residues of proteins into
citrulline. These enzymes are expressed in most mammalian
tissues. The PAD2 enzyme isoform is broadly distributed in
murine tissues and has been reported to be responsible for
most peptidylarginine deiminase activity, which is abrogated
in PAD2 knockout mice [22, 29]. Protein citrullination by
PAD enzymes can be induced under inflammatory condi-
tions or it can be triggered in vitro by LPS, TNF, ATP, or
other molecular stimulants [30–33]. Nevertheless, this induc-
tion depends on the PAD substrate because the specificities
of PAD2 and PAD4 are distinct [34, 35]. The present
study demonstrated that PAD2 and PAD4 are broadly
(a) (b)
(c) (d)
Figure 8: Ro60 expressed in apoptotic cells. (a) Ro60 is stained as red immunofluorescence. (b) Nuclei counterstained with DAPI as blue
fluorescence. (c) Double fluorescence Ro ribonucleoprotein (red) in apoptotic cells (green) tagged by TUNEL assay in double fluorescence
test. (d) The results of a triple fluorescence show Ro in red outside of apoptotic nuclei in green, and some of the remaining nuclei are
stained in blue by DAPI.
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expressed in the salivary gland of Balb/c mice. However,
PAD4 was the dominant enzyme, and the interaction
between PAD4 with protein tyrosine phosphatase enhances
protein citrullination [36, 37].
Regarding the presence of Ro and La ribonucleoproteins
in murine salivary glands, both ribonucleoproteins were
widely distributed in acinar and ductal cells, because they
normally perform a function in the cellular physiology. Also,
we demonstrated that Ro60 and La ribonucleoproteins are
citrullinated in this model; however, their hypercitrullination
can be of pathogenic importance because this process may
foster the production of autoantigens.
The potential effect of Ro60 citrullination has been tested
in vitro by other investigators using synthetic peptides, the
arginine residues 174 and 184 were transformed into citrul-
line, and the main effect of this modification was an increase
in the antibody binding strength in comparison to unmodi-
fied linear epitopes [38]. Besides, the results from a proteomic
analysis demonstrated that a broad repertoire of proteins,
including La ribonucleoprotein, can be posttranslationally
modified in the salivary glands of patients with Sjögren’s
syndrome [39]. The aforementioned observations are consis-
tent with the present findings.
We have previously noted that posttranslational pro-
tein modifications that are dependent on PAD may occur
in the salivary glands of patients with Sjögren’s syndrome,
and this mechanism could be important for disease patho-
genesis because salivary glands constitute an accessible
target via the salivary ducts for different environmental
triggers. Consequently, external stimulation can activate
PAD enzymes, which in turn can modify proteins that
may contribute to the autoimmune response. We believe
that citrullination is a formidable catalytic mechanism that
underlies the production of autoantigens that can poten-
tially abrogate immune tolerance.
Considering the difficulty associated with obtaining
patient salivary glands to assess potential inducers of PAD
activity, we designed the present experimental approach
using salivary glands of Balb/c mice to answer our primary
question. Our results suggest that the bacterial products of
Gram-negative bacteria such as LPS are capable of inducing
PAD activity. Similarly, some proinflammatory cytokines,
such as TNF produced by local inflammation, may
activate PAD enzymes and citrullinate Ro and La ribonu-
cleoproteins in situ. Therefore, the reason for using a
serum of a primary Sjögren’s syndrome with CCP anti-
body and positive for anti-Ro60 and anti-La antibodies,
as well as the lack of commercial antibodies against citrul-
linated nonhistone proteins, encouraged us to purify CCP
antibodies to identify possible areas of citrulination in
parotids of Balb/c mice, since the human CCP antibodies
have been successfully used by others for tissue labelling
[40]. Consequently, our proposal rather than an animal
model of Sjögren’s disease is a tool to demonstrate how
the enzymatic PAD machinery can posttranslationally
modify normal proteins by transforming them into
(a) (b)
(c) (d)
Figure 9: The translocation of Ro60 ribonucleoproteins onto apoptotic membranes as shown in the Annexin assay. (a) Nuclear staining in
blue by DAPI. (b) Ro60 stained in red. (c) Apoptotic membranes (green). (d) Arrows correspond to the overlapping image of Annexin (green)
with Ro60 (red) in orange (enlarged image in square).
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possible autoantigens as a way to understand one of the
multiple triggers of autoimmunity.
In addition,molecular triggers such asATP, LPS, andTNF
induce apoptosis in acini and ducts, and under certain exper-
imental conditions, ATP and LPS trigger the inflammasome
pathway, resulting in apoptosis [14, 41, 42]. In the present
study, different degrees of apoptosis were induced in salivary
glands. This finding is not surprising; however, it is important
to mention that Ro60 and La autoantigens were translocated
to the cell surface on apoptotic membranes, which suggests
that, via apoptosis, Ro and La intracellular autoantigens
become accessible to the antigen-presenting cells.
5. Conclusions
Based on our findings, it is possible to hypothesize that an
initial and nonspecific external trigger (microorganisms,
chemical products, or another type of trigger) can activate
the PAD pathway, changing normal proteins into possible
autoantigens. Citrullinated proteins in primed autoim-
mune class II MHC molecules and autoreactive lymphocyte
clones can generate an autoimmune response similar to that
of Sjögren’s syndrome. However, this hypothesis must be
further explored.
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